Advertisement

The Role of Granzyme A in Cytotoxic Lymphocyte-Mediated Lysis

  • Mark S. Pasternack

Abstract

Despite considerable information regarding the structure and expression of granzymes, the serine proteases that reside in the cytotoxic granules of cytotoxic T lymphocytes (CTL), little is known about their physiologic substrates or their role in the economy of these effector cells. From a conceptual framework, such proteases may act on the effector cells themselves (“cis” action), on the target cells (“trans”), or in a more nonspecific fashion; current information remains sketchy and controversial. In this chapter, the functional properties and possible physiologic roles of CTL granzymes will be reviewed, with particular reference to granzyme A.

Keywords

Large Granular Lymphocyte Target Cell Lysis Cytotoxic Granule Serine Esterase Mediate Lysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allbritton NK. Verret CR, Wolley RC, Eisen HN (1988): Calcium ion concentrations and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes. J Exp Med 167: 514–527CrossRefGoogle Scholar
  2. Arends MJ, Morris RG, Wyllie AH (1990): Apoptosis: The role of the endonuclease. Am J Pathol 136: 593–608Google Scholar
  3. Berke G, Rosen D (1988): Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. J Immunol 141: 1429–1436Google Scholar
  4. Borer RA, Lehner CF, Eppenberger HM, Nigg EA (1989): Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379–390CrossRefGoogle Scholar
  5. Dennert G, Podack ER (1983): Cytolysis by H-2-specific T killer cells: Assembly of tubular complexes on target membranes. J Exp Med 157: 1483–1495CrossRefGoogle Scholar
  6. Dennert G, Anderson CG, Prochazka G (1987): High activity of N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in vivo-induced cytotoxic effector cells. Proc Natl Acad Sci USA 84: 5004–5008CrossRefGoogle Scholar
  7. Duke RC, Persechini PM, Chang S, Liu C, Cohen JJ, Young JD (1989): Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med 170: 1451–1456CrossRefGoogle Scholar
  8. Fankhauser C, Izaurralde E, Adachi Y, Wingfield P, Laemmli UK (1991): Specific complex of human immunodeficiency virus type 1 Rev and nucleolar B23 proteins: Dissociation by the Rev response element. Mol Cell Biol 11: 2567–2575Google Scholar
  9. Fruth U. Nerz G, Prester M, Simon HG, Kramer MD, Simon MM (1988): Determination of T cells expressing the T-cell specific serine proteinase 1 (TSP-1) reveals two types of L3T4 + T lymphocytes. Eur J Immunol 18: 773–781CrossRefGoogle Scholar
  10. Garcia-Sanz JA, MacDonald HR, Jenne DE, Tschopp J, Nabholz M (1990): Cell specificity of granzyme gene expression. J Immunol 145: 3111–3118Google Scholar
  11. Garcia-Sanz JA, Plaetinck G, Velotti F, Masson D, Tschopp J, MacDonald HR, Nabholz M (1987): Perforin is present only in normal activated Lyt2 + T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets. EMBO J 6: 933–938Google Scholar
  12. Gershenfeld HK, Weissman IL (1986): Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 232: 854–858CrossRefGoogle Scholar
  13. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL (1992): Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Nall Acad Sci USA 89: 549–553CrossRefGoogle Scholar
  14. Gromkowski SH, Brown TC, Masson D, Tschopp J (1988): Lack of DNA degradation in target cells lysed by granules derived from cytolytic T lymphocytes. J Immunol 141: 774–778Google Scholar
  15. Gruber BL, Schwartz LB, Ramamurthy NS, Irani A, Marchese MJ (1988): Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 140: 3936–3942Google Scholar
  16. Hameed A, Olsen KJ, Lee M, Lichtenheld MG, Podack ER (1989): Cytolysis by Ca-permeable transmembrane channels: Pore formation causes extensive DNA degradation and cell lysis. J Exp Med 169: 765–777CrossRefGoogle Scholar
  17. Hayes MP, Berrebi GA, Henkart PA (1989): Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 170: 933–946CrossRefGoogle Scholar
  18. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C (1990): Genes encoding tumour necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 87: 2239–2243CrossRefGoogle Scholar
  19. Henkart MP, Henkart PA (1982): Lymphocyte mediated cytolysis as a secretory phenomenon. Adv Exp Med Biol 146: 227–242Google Scholar
  20. Henkart PA, Berrebi GA, Takayama H, Munger WE, Sitkovsky MV (1987): Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes. J Immunol 139: 2398–2405Google Scholar
  21. Henkart PA, Millard PJ. Reynolds CW, Henkart MP (1984): Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J Exp Med 160: 75–93CrossRefGoogle Scholar
  22. Hudig D, Allison NJ, Kam C. Powers JC (1989): Selective isocoumarin serine protease inhibitors block RNK-16 lymphocyte granule-mediated cytolysis. Mol Immunol 26: 793–798Google Scholar
  23. Hudig D, Allison NJ, Pickett TM, Winkler U, Kam C, Powers JC (1991): The function of lymphocyte pro-teases: Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors. J Immunol 147: 1360–1368Google Scholar
  24. Hudig D, Callewaert DM, Redelman D, Allison NJ, Krump M, Tardieu B (1988): Lysis by RNK-16 cytotoxic lymphocyte granules: Rate assays and conditions to study control of cytolysis. J Immunol Methods 115: 169–177CrossRefGoogle Scholar
  25. Hudig D, Gregg, NJ, Kam C, Powers JC (1987): Lymphocyte granule-mediated cytolysis requires serine protease activity. Biochem Biophys Res Commun 149: 882–888CrossRefGoogle Scholar
  26. Jenne DE, Tschopp J (1988): Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 103: 53–71CrossRefGoogle Scholar
  27. Kirstein M, Baglioni C (1986): Tumor necrosis factor induces synthesis of two proteins in human fibroblasts. J Biol Chem 261: 9565–9567Google Scholar
  28. Klein JL, Selvakumar A, Trapani JA, Dupont B (1990): Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C). Tissue Antigens 35: 220–228CrossRefGoogle Scholar
  29. Kumar S, Baglioni C (1991): Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 266: 20960–20964Google Scholar
  30. Liu C, Jiang S, Persechini PM, Zychlinsky A, Kaufmann Y, Young, JD (1989): Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. J Exp Med 169: 2211–2225CrossRefGoogle Scholar
  31. Lowrey DM, Aebischer T, Olsen K, Lichtenheld M, Rupp F, Hengartner H, Podack ER (1989): Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci USA 86: 247–251CrossRefGoogle Scholar
  32. MacDermott RP, Schmidt RE, Caulfield JP, Hein A, Bartley GT, Ritz J, Schlossman SF, Austen KF, Stevens RL (1985): Proteoglycans in cell-mediated cytotoxicity: Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J Exp Med 162: 1771–1787CrossRefGoogle Scholar
  33. Masson D, Tschopp J (1985): Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem 260: 9069–9072Google Scholar
  34. Masson D. Tschopp J (1987): A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49: 679–685CrossRefGoogle Scholar
  35. Masson D, Nabholz M, Estrade C, Tschopp J (1986): Granules of cytolytic T-lymphocytes contain two serine esterases. EMBO J 5: 1595–1600Google Scholar
  36. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991): Rapid and specific conversion of precursor interleukin 1-beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174: 821–825CrossRefGoogle Scholar
  37. Muller C, Kagi D, Aebischer T, Odermatt B, Held W, Podack ER, Zinkernagel RM, Hengartner H (1989): Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol 19: 1253–1259CrossRefGoogle Scholar
  38. Munger WE, Berrebi GA, Henkart PA (1988): Possible involvement of CTL granule proteases in target cell DNA breakdown. Immunol Rev 103: 99–109CrossRefGoogle Scholar
  39. Ojcius DM, Zheng LM, Sphicas EC, Zychlinsky A, Young JD (1991): Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling. J Immunol 146: 4427–4432Google Scholar
  40. Ostergaard HL, Kane KP, Mescher MF, Clark WR (1987): Cytotoxic T lymphocyte mediated lysis without release of serine esterase. Nature 330: 71–72CrossRefGoogle Scholar
  41. Pasternack MS, Eisen HN (1985): A novel serine esterase expressed by cytotoxic T lymphocytes. Nature 314: 743–745CrossRefGoogle Scholar
  42. Pasternack MS, Bleier KJ, McInerney TN (1991): Granzyme binding to target cell proteins: Granzyme A binds to and cleaves nucleolin in vitro. J Biol Chem 266: 14703–14708Google Scholar
  43. Pasternack MS, Verret CR, Liu MA, Eisen HN (1986): Serine esterase in cytolytic T lymphocytes. Nature 322: 740–743CrossRefGoogle Scholar
  44. Paul NL, Ruddle NH (1988): Lymphotoxin. Anno Rev Immunol 6: 407–438CrossRefGoogle Scholar
  45. Peters PJ, Borst J, Oorschot V, Fukada M, Krahenbuhl O. Tschopp J, Slot JW, Geuze HJ (1991): Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173: 1099–1109Google Scholar
  46. Podack ER (1986): Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes. J Cell Biochem 30: 133–170CrossRefGoogle Scholar
  47. Podack ER, Konigsberg PJ (1984): Cytolytic T cell granules: Isolation, structural, biochemical, and functional characterization. J Exp Med 160: 695–710.CrossRefGoogle Scholar
  48. Podack ER, Young JD, Cohn ZA (1985): Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci USA 82: 8629–8633CrossRefGoogle Scholar
  49. Ruggiero V, Johnson SE, Baglioni C (1987): Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell Immunol 107: 317–325CrossRefGoogle Scholar
  50. Sayers TJ, Wiltrout TA, Sowder R, Munger WL, Smyth MJ, Henderson LE (1992): Purification of a factor from the granules of a rat natural killer cell line (RNK) that reduces tumor cell growth and changes tumor morphology: Molecular identity with a granule serine protease (RNKP-1). J Immunol 148: 292–300Google Scholar
  51. Schick B, Austen KF, Schwartz LB (1984): Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. J Immunol 132: 2571–2577Google Scholar
  52. Schmid DS, McGrath KM, Hornung RL, Paul N, Ruddle NH (1987): Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. Lymphokine Res 6: 195–200Google Scholar
  53. Schmid DS, Tite JP, Ruddle NH (1986): DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proc Natl Acad Sci USA 83: 1881–1885CrossRefGoogle Scholar
  54. Schmidt RE, MacDermott RP, Bartley G, Bertovich M, Amato DA, Austen KF, Schlossman SF, Stevens RL, Ritz J (1985): Specific release of proteoglycans from human natural killer cells during target lysis. Nature 318: 289–291CrossRefGoogle Scholar
  55. Semenkovich CF, Ostlund RE, Olson MOJ, Yang JW (1990): A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 29: 9708–9713CrossRefGoogle Scholar
  56. Shi L, Kraut RP, Aebersold R, Greenberg AH (1992): A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175: 553–566CrossRefGoogle Scholar
  57. Simon MM, Fruth U, Simon HG, Kramer MD (1987a): Evidence for the involvement of a T cell associated serine proteinase (TSP-1) in cell killing. Ann Inst Pasteur 138: 285–289Google Scholar
  58. Simon MM, Hoschutzky H, Fruth U, Simon H, Kramer MD (1986): Purification and characterization of a T cell specific serine proteinase (TSP-1) from cloned cytolytic T lymphocytes. EMBO J 5: 3267–3274Google Scholar
  59. Simon MM, Simon HG, Fruth, U, Epplen J, MullerHermelink HK, Kramer MD (1987b): Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. Immunology 60: 219–230Google Scholar
  60. Suffys P, Beyaert R, van Roy F, Fiers W (1988): Involvement of a serine protease in tumour-necrosisfactor-mediated cytotoxicity. Eur J Biochem 178: 257–265CrossRefGoogle Scholar
  61. Takayama H, Trenn G, Humphrey W, Bluestone JA, Henkart PA, Sitkovsky MV (1987): Antigen receptor-triggered secretion of a trypsin-like esterase from cytotoxic T lymphocytes. J Immunol 138: 566–569Google Scholar
  62. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P (1991): A polyadenylate binding protein localized to the granules of cytotoxic lymphocytes induces DNA fragmentation in target cells. Cell 67: 629–639CrossRefGoogle Scholar
  63. Trenn G, Takayama H, Sitkovsky MV (1987): Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature 330: 72–74CrossRefGoogle Scholar
  64. Velotti F, MacDonald HR, Nabholz M (1987): Granzyme A secretion by normal activated Lyt 2+ and L3T4+ T cells in response to antigenic stimulation. Eur J Immunol 17: 1095–1099CrossRefGoogle Scholar
  65. Wyllie AH, Morris RG, Smith AL, Dunlop D (1984): Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142: 67–77CrossRefGoogle Scholar
  66. Young, JD, Clark WR, Liu C, Cohn ZA (1987): A calcium-and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes. J Exp Med 166: 1894–1899CrossRefGoogle Scholar
  67. Young JD, Leong LG, Liu C, Damiano A, Cohn, ZA (1986a). Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after ionophore stimulation. Proc Natl Acad Sci USA 83: 5668–5772CrossRefGoogle Scholar
  68. Young JD, Leong LG, Liu C, Damiano A, Wall DA, Cohn ZA (1986b): Isolation and characterization of a serine esterase from cytolytic T cell granules. Cell 47: 183–194CrossRefGoogle Scholar
  69. Young LHY, Joag SV, Zheng L, Lee C, Lee Y, Young JD (1990): Perforin-mediated myocardial damage in acute myocarditis. Lancet 2: 1019–1021CrossRefGoogle Scholar
  70. Young LHY, Peterson LB, Wicker LS, Persechini PM, Young JD (1989): In vivo expression of perforin by CD8 + lymphocytes in autoimmune disease: Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 143: 3994–3999Google Scholar

Copyright information

© Birkhäuser Boston 1993

Authors and Affiliations

  • Mark S. Pasternack

There are no affiliations available

Personalised recommendations